Swift Run Capital Management LLC purchased a new position in shares of Stericycle Inc. (NASDAQ:SRCL) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 36,760 shares of the company’s stock, valued at approximately $3,827,000. Stericycle accounts for 2.4% of Swift Run Capital Management LLC’s holdings, making the stock its 16th largest position.
Several other institutional investors have also recently added to or reduced their stakes in the stock. Canada Pension Plan Investment Board raised its position in Stericycle by 54.1% in the first quarter. Canada Pension Plan Investment Board now owns 1,415 shares of the company’s stock worth $179,000 after buying an additional 497 shares in the last quarter. Meeder Asset Management Inc. purchased a new position in Stericycle during the second quarter worth approximately $155,000. Jones Financial Companies Lllp purchased a new position in Stericycle during the first quarter worth approximately $203,000. Trust Co. of Vermont raised its position in Stericycle by 70.9% in the second quarter. Trust Co. of Vermont now owns 1,784 shares of the company’s stock worth $186,000 after buying an additional 740 shares in the last quarter. Finally, Barnett & Company Inc. purchased a new position in Stericycle during the first quarter worth approximately $228,000. 92.72% of the stock is currently owned by institutional investors.
Shares of Stericycle Inc. (NASDAQ:SRCL) traded up 1.47% during midday trading on Friday, hitting $75.47. 977,444 shares of the stock traded hands. The stock has a 50 day moving average of $80.45 and a 200 day moving average of $98.03. Stericycle Inc. has a 1-year low of $72.89 and a 1-year high of $151.57. The company has a market capitalization of $6.42 billion, a P/E ratio of 26.56 and a beta of 0.20.
Stericycle (NASDAQ:SRCL) last released its quarterly earnings data on Thursday, July 28th. The company reported $1.18 EPS for the quarter, meeting the consensus estimate of $1.18. The company earned $891.60 million during the quarter, compared to the consensus estimate of $910.29 million. Stericycle had a return on equity of 14.84% and a net margin of 7.22%. The firm’s revenue for the quarter was up 24.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.14 EPS. Equities research analysts predict that Stericycle Inc. will post $4.67 earnings per share for the current fiscal year.
A number of research firms have recently commented on SRCL. Zacks Investment Research lowered shares of Stericycle from a “buy” rating to a “hold” rating in a research report on Thursday, July 14th. Wedbush dropped their target price on shares of Stericycle from $95.00 to $85.00 and set a “neutral” rating on the stock in a research report on Thursday, September 22nd. Northcoast Research lowered shares of Stericycle from a “buy” rating to a “neutral” rating in a research report on Tuesday, September 20th. Robert W. Baird dropped their target price on shares of Stericycle from $99.00 to $85.00 and set a “neutral” rating on the stock in a research report on Friday, September 23rd. Finally, Jefferies Group reaffirmed a “buy” rating and set a $125.00 target price (down previously from $140.00) on shares of Stericycle in a research report on Friday, July 29th. Four analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $103.54.
In other Stericycle news, EVP John P. Schetz sold 1,398 shares of the firm’s stock in a transaction on Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total transaction of $114,426.30. Following the completion of the sale, the executive vice president now owns 1,088 shares of the company’s stock, valued at approximately $89,052.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Rodney F. Dammeyer sold 10,188 shares of the firm’s stock in a transaction on Wednesday, August 17th. The shares were sold at an average price of $85.50, for a total value of $871,074.00. Following the sale, the director now directly owns 10,188 shares of the company’s stock, valued at approximately $871,074. The disclosure for this sale can be found here. 3.30% of the stock is owned by insiders.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc. (NASDAQ:SRCL).
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.